We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Theracryf Plc | LSE:TCF | London | Ordinary Share | GB00BSVYN304 | ORD 0.25P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.75 | 0.00 | 08:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 0.70 | 0.80 | 0.75 | 0.75 | 0.75 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 422k | -4.04M | -0.0147 | -0.51 | 2.06M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 0.75 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 02/5/2024 | 10:47 | UK RNS | Theracryf PLC Holding(s) in Company |
| 02/5/2024 | 07:00 | UK RNS | Theracryf PLC Chronos Integration Update |
| 02/5/2024 | 07:00 | UK RNS | Theracryf PLC Total Voting Rights |
Theracryf (TCF) Share Charts1 Year Theracryf Chart |
|
1 Month Theracryf Chart |
Intraday Theracryf Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 15/5/2024 | 17:09 | Theracryf the new Evgen onwards and upwards | 13 |
| 29/9/2017 | 15:06 | Terra Catalyst Fund | 114 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 15/5/2024 09:20 by Theracryf Daily Update Theracryf Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker TCF. The last closing price for Theracryf was 0.75p.Theracryf currently has 274,888,000 shares in issue. The market capitalisation of Theracryf is £2,061,660. Theracryf has a price to earnings ratio (PE ratio) of -0.51. This morning TCF shares opened at 0.75p |
Posted at 15/5/2024 15:19 by clocktower That does not surprise me at this sort of level markth126 - out of interest what price are the bidding for 1 million, I ask because I just looked at the last few days trades, and the picture is mixed. |
Posted at 10/5/2024 07:12 by terrydevlin1 I agree with your comment Clock Tower. It is incredibly disappointing to have no new deals signed up for SFX-01 since the Stalicla deal. There seems so little news now about SFX-01 in the past 10 months.The sad reality is that TCF cannot afford to do their own trials so they cannot do much to prove the drug is effective and it seems like they cannot get anyone to trial it for them. The Stalicla deal is so huge to TCF that they have no option but to wait for Stalicla to decide what they will do and when they will do it. It is TCF’s only potential income stream and money is running out. It is over a quarter of a year since the dispute was issued and no news at all. It doesn’t feel like there will be any news any time soon either. I feel for all investors who invested as a result of the Stalicla deal announcement in 2022. At that time with £10m in the bank, Juvenesense having a deal with SFX-01 and milestone payments of up to $160m with Stalicla it seemed like this share had great potential. I wish I never had stumbled on that RNS. |
Posted at 02/5/2024 07:19 by clocktower Well markth126 all guff in that RNS as nothing about the due money from Stalicla.Have you rung shyster Jones and asked him what’s going on? From the looks of the share price it would seem that some of those 62 million new shares have been sold, bringing the stock price down. Good luck maybe there will be better news when the next RNS is released. |
Posted at 13/7/2017 20:40 by rjmahan Glad I sold out of this - lucky escape. I had hoped they would be able to sell down property and repay debt but it obviously hasnt happened like that.Still not entirely convinced its a complete no hoper, debt / NAV was 57% !, telecom assets are high quality - though there is a lot of junk in there too. There was a eur 20m (from memory) payment due in 2017 - part of reason I sold out. Surely can be renegotiated again? Dont entirely trust laxley not to try to pick up TCF on the cheap... Dont think we are anywhere near the bottom yet though.... |
Posted at 02/12/2016 21:35 by rjmahan I dont know but you could ask them. I think the debt is reasonably short term so no guarantees either way....Dont forget share is at 40% of NAV... Will revalue once the debt is paid down a bit more and it can start paying dividends... |
Posted at 18/4/2016 11:02 by praipus 8(th) April 2016. TERRA CATALYST FUND. Net Asset Value of the CompanyThe Directors of Terra Catalyst Fund ("the Company") wish to announce that the final Net Asset Value for the Company as of 31(st) March 2016 was 203.33 pence per share. |
Posted at 04/3/2016 22:45 by praipus RNS Number : 1682RTerra Catalyst Fund 04 March 2016 4(th) March 2016 TERRA CATALYST FUND Net Asset Value of the Company The Directors of Terra Catalyst Fund ("the Company") wish to announce that the final Net Asset Value for the Company as of 29(th) February 2016 was 200.39 pence per share. -ends- |
Posted at 31/12/2014 17:51 by rjmahan Sales + Low liquidity. If you read report TCF wont be able to pay out for several years (I estimate 4) unless sold. However after 4 years I recon this can have a 10% yield. |
Posted at 23/12/2014 18:00 by praipus Curious price weakness. results and investment environment look ok IMHO |
Posted at 22/8/2014 15:10 by edwardt well worth the wait - glad i hang around. interesting also to note, despite the enormous rise in the share price, the discount has actually widened out! i can not say that has happened to me before! |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
